InsightNodes

Executive Summary

Generated July 30, 2026

Semiconductor Manufacturing

Tekscend Photomask

Emerging56% confidenceProfile verified Jul 18, 2026

Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.

1

Chokepoint Score

1 other entity structurally depend on this one

Headquarters

Tokyo, Japan

Employees

2,000 (2026, approximate)

Founded

2022

Listing

429A · Tokyo Stock Exchange

Market Cap

JPY 352.19B

Revenue (TTM)

JPY 129.58B

Price

JPY3,545 (-17.27%)

Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.

Overview

Tekscend Photomask is a Japanese semiconductor photomask manufacturer, spun off from Toppan Printing (rebranded from Toppan Photomask in 2024), supplying the reticles used to pattern chip designs onto silicon wafers. Fiscal 2026 revenue rose 9.8% to JPY 129.6 billion with profit surging 150.9% to JPY 24.9 billion (19% margin, up from 8.4%); the company resumed dividends at JPY 56 per share and projects further growth to JPY 140.1 billion in FY2027, while expanding capacity with a new Singapore facility expected online by late 2026 or early 2027.

Strategic Connections

  • Extreme Ultraviolet Lithography: Tekscend Photomask manufactures the photomasks used in EUV and conventional lithography processes to pattern chip designs onto wafers.
  • Semiconductor Manufacturing: Tekscend Photomask supplies photomasks, a critical input for the broader semiconductor manufacturing industry.

Strategic Risks

  • Concentrated photomask market with high capital intensity and long lead times

Future Outlook

  • Capacity expansion in Singapore aimed at capturing rising advanced-node photomask demand

Sources

3 sources, 49% average source confidence — full citations in the Full Analyst Report.

Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.

Viewing the Executive Summary switch to the Full Analyst Report.